Toggle light / dark theme

In a recent study, a team from the Neurobiota Research Center in Korea has discovered that reducing gut dysbiosis partially alleviates the cognitive impairment associated with Alzheimer’s disease. This may seem puzzling, as the gut and the brain are separate and relatively distant organs, but this research makes sense in the context of chronic inflammation.

Inflammaging

Under normal circumstances, inflammation is a short-term measure in response to infection: immune cells are directed towards the inflamed area and handle the infection, and then the inflammation dies down. However, chronic inflammation causes harm to our organs; it is the main form of altered intercellular communication, which is one of the hallmarks of aging. The protein complex NF-kB, the master regulator of inflammation, is the main culprit of inflammaging, and it is specifically discussed in this paper.

Aren Jay shared this cogent article to my Timeline… It is not new even Hippocrates was able to determine that the gut causes and or assists in all diseases. But the 19th and 20th centuries researchers began saying that microbes are good for mankind which sent science reeling through generations until this day… Respect r.p.berry & AEWR wherein we have developed a formula and Algorithm that deals with this very serious problem completely. A very expensive cure but one that will take Woman-Man past the Escape Velocity so many have written about… https://gerevivify.blogspot.com/


Recent research has found that bacteria in the gut can affect people’s mental state, leading to mood, cognition and behavioural problems. But in TCM, the link between the gut and all of the body’s organs has long been recognised.

In one of the largest studies of its kind, researchers at Orlando Health are making new progress in finding ways to detect a traumatic yet sinister brain injury—and getting closer to preventing further damage.

Subconcussive injuries often show no symptoms or immediate effects, but can cause wear and tear on the brain over time with repeated injuries. The latest study, published in the journal BMJ Paediatrics Open, includes more than 700 emergency room patients—children and adults. The study gets us closer to developing a standard blood test to spot these injuries as early as possible.

“A unique feature of this study is that it includes patients who hit their heads but have no symptoms,” said Linda Papa, MD, lead author of the study and emergency medicine doctor at Orlando Health. “This group is rarely—if ever—included in biomarker studies.”

Scientists have identified a class of drugs that may have potential to treat a rare and deadly form of brain cancer that affects young children.

The research team, led by Ranjit Bindra, MD, PhD, and colleagues at the Yale Cancer Center, also included co-senior authors Charles Brenner, PhD, professor and DEO of biochemistry at the University of Iowa Carver College of Medicine, and Michael E. Berens, PhD, from the Translational Genomics Research Institute in Phoenix.

The findings, published Aug. 22 in Nature Communications, focus on Diffuse Intrinsic Pontine Glioma (DIPG), a rare, incurable cancer that affects the brainstem in children under age 10. Previous work had identified mutations in a gene called PPM1D as a cause of this cancer.

Nootropics are colloquially known as “smart drugs” – substances that increase cognitive function in healthy people. In this video, bestselling author Dave Asprey discusses two naturally occurring nootropics: caffeine and nicotine.

Microdosing one milligram of the latter — about 5 to 10 percent of a cigarette’s worth — may even protect against Alzheimer’s.

ME Conferences is organizing “18th International Conference on Gastroenterology and Digestive Disorders” during September 16–17, 2019, Dubai, UAE. Conference highlights the theme- Improving Access in Gastroenterology: From Past to Future.

Gastro Meet 2019 is a leading platform for a focused agenda of the current research in the field of gastroenterology which includes, guest lectures, keynotes, symposiums, workshops, exhibitions, panel discussions, and poster sessions. We invite Gastroenterologists, Hepatologists, General Physicians, Microbiologists, Oncologists, Surgeons, Researchers, Students, and Business delegates to join us at Dubai in August 2018 for the 2-day power packed Gastroenterologists Meet.

September 16 (Monday) — 17 (Tuesday)